SEL-128 program

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSEL-128 program
Drug Alias Nameprotein kinase inhibitors (Selvita)protein kinase modulators (Selvita)MELK inhibitors (Selvita)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaternal embryonic leucine zipper kinase inhibitors
TargetsMaternal embryonic leucine zipper kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRyvu Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRyvu Therapeutics Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A